Psychedelic Stocks,Shroom News Numinus Submits Clinical Trial Application For Naturally Extracted Psilocybe Formulation NBIO-01 By Dennis Mutua January 17, 2022 Mental health and wellness company focusing on administering psychedelic medicine with holistic integrated psychotherapy Numinus Wellness Inc. (TSX: NUMI) has submitted clinical trial application (CTA) to Health Canada for the Pha...
Psychedelic Stocks BREAKING NEWS: DEA Wants to Ban More Psychedelics By Dennis Mutua January 14, 2022 The United States Drug Enforcement Administration (DEA) is preparing to pass a rule that would place five tryptamine hallucinogens on Schedule I of the Controlled Substances Act (CSA). These compounds would then be as illegal as h...
Psychedelic Stocks Join Us January 26! The Future of Psychedelics By Dennis Mutua January 14, 2022 Do you want to join us for a webcast about the future of psychedelics? If so, you won’t want to miss the Seminar Group’s upcoming, day-long psychedelics webcast, Legal and Regulatory Landscape for Psychedelics. The webcast wil...
Spotlight Stock,Trends & Articles Mydecine to Launch SASSP in Canada to Expand Patients’ Access to Psychedelic-Assisted Psychotherapy By Dennis Mutua January 14, 2022 Biotechnology company specializing in research, development and acceptance of naturally extracted medicine for clinical management and mental wellness Mydecine Innovations Group Inc. (NEO: MYCO) (OTCMKTS: MYCOF) announced that it ...
Psychedelic Stocks Oregon Psilocybin: Business Issues By Dennis Mutua January 13, 2022 We’ve been taking early calls on Oregon psilocybin for over a year, going back to when Measure 109 passed. I’m always happy to talk to people, but there simply isn’t much to do yet. Currently, the Oregon Psilocybin Advisory ...
Spotlight Stock,Trends & Articles MYND Life Sciences Enters Into a Research Agreement With University of British Columbia By Dennis Mutua January 13, 2022 Neuro-pharmaceutical company drug development company advancing medicines that leverage on psychedelic compounds Mynd Life Sciences Inc. (CSE: MYND) (OTCMKTS: MYNDF) has entered into a collaborative research agreement with Unive...
Featured,Trends & Articles FDA Grants Wesana Health Pre-IND Meeting For SANA-013 By Dennis Mutua January 12, 2022 Emerging life sciences company specializing in development and delivery of psychedelic and naturally extracted therapies to treat traumatic brain injuries Wesana Health Holdings Inc. (CSE: WESA) (OTCQB: WSNAF) announced having bee...
Psychedelic Stocks,Shroom News Mydecine Completes Supercomputing AI Modeling for Psychedelic Drug Development By Dennis Mutua January 11, 2022 Biotechnology company specializing in research, development and acceptance of naturally extracted medicine for better clinical trial management and mental health welfare Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) ann...